FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
675 letters match. Newest first.
-
DevicesDr. Joel Kaplan Inc.
FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium -
DevicesNeitz Instruments Company Ltd.
FDA warns Neitz Instruments its ophthalmoscope is misbranded because medical device reporting procedures are inadequate.
Medium -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DevicesSonesta Medical AB
FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.
Medium -
DevicesFresenius Medical Care AG & Co. KGaA
FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.
High risk -
FoodNutra Blend, LLC subsidiary of Land O’Lakes
Nutra Blend's medicated calf feed contained unintended monensin, killing calves and prompting a recall.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.
High risk -
DrugsXiamen Wally Bath Manufacture Co., Ltd.
FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
DrugsElemental Herbs Inc. d/b/a ALL good
Elemental Herbs (ALL good) cited for CGMP failures and unapproved, misbranded Goop Skin Recovery Balm.
High risk -
DrugsSaruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi
FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.
High risk -
DevicesMing Fai Industrial Co LTD
Ming Fai Industrial, a Shenzhen device maker, lacked validation and acceptance-status controls for ultrasound gel and probe covers.
High risk -
DevicesAcrostak Schweiz AG
FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.
High risk -
DevicesNeurotris, Inc. dba A1 Engineering
FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.
High risk -
FoodBiorica International Corp.
FDA warned Biorica International that its Plaquex Oral Dietary Supplement is an unapproved new drug because website claims promote disease treatment and prevention.
High risk -
DevicesWAVi Co.
FDA says WAVi sold its unapproved WAVi Desktop brain-assessment device for clinical use and had quality-system failures.
High risk -
FoodGolden Natural Products
FDA says Golden Natural Products lacked required foreign supplier safety checks for imported dried fruit and noodles.
Medium -
DrugsAntonio E. Blanco, M.D./Vista Health Research, LLC
FDA cited Dr. Antonio E. Blanco/Vista Health Research for enrolling ineligible trial subjects and missing required safety imaging.
High risk -
DevicesAbiomed Inc.
Abiomed marketed Impella Connect System without PMA and had CGMP, complaint, and MDR reporting failures.
High risk -
FoodIkal LLC
FDA warns Ikal LLC that it lacked required foreign supplier verification checks for imported fresh avocados.
High risk -
DrugsLuis Javier Pena-Hernandez, M.D., FCCP
FDA warns Dr. Pena-Hernandez over ineligible subject enrollment and lapsed IRB approval for investigational drugs.
High risk -
BiologicsFresenius Kabi AG
FDA warned Fresenius Kabi’s Fenwal plant in Puerto Rico about unsafe manufacturing of blood-pack units and solutions.
High risk -
FoodPT. Winson Prima Sejahtera
FDA says PT. Winson Prima Sejahtera's ready-to-eat yellowfin tuna seafood safety plan lacks pathogen and histamine controls.
High risk -
FoodMoorish Science Temple, The Divine and National Movement of North America, Inc; #13 The Moorish American National Republic dba Moor Herbs, Inc.
FDA warned Moor Herbs that its herbal products are unapproved drugs with disease claims and are made without required supplement quality controls.
High risk -
DevicesBYD Precision Manufacture Co., Ltd
FDA warned BYD Precision Manufacture over quality-system and reporting failures for surgical masks and an N95 respirator made in Shenzhen, China.
Medium -
FoodDel Valle Import & Export 3, Inc. DBA El Progreso Imports
FDA warns Vernon, CA importer El Progreso Imports that it lacked required foreign supplier verification records for most imported foods.
Medium -
DevicesCaltag Medsystems Ltd
FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.
Medium -
DrugsGreen Pharmaceutical Co. Ltd.
FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.
High risk -
FoodOsmosis, LLC
Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.
High risk -
FoodReckitt/Mead Johnson Nutrition
FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.
High risk -
FoodPerrigo Wisconsin, LLC
FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.
High risk -
DrugsCosmobeauti Laboratories & Manufacturing Inc.
FDA warns Cosmobeauti Laboratories over manufacturing rule violations for OTC sunscreen drugs, including backdated batch records and missing microbial testing.
High risk -
FoodAmor Nino Foods, Inc.
FDA says Amor Nino Foods' ready-to-eat Hawaiian-style aku tuna sticks were made under an inadequate seafood safety plan and without required monitoring.
High risk -
DevicesKing Systems Corp. dba Ambu, Inc.
FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.
High risk -
DrugsK. Boeun Pharmaceutical Co., Ltd.
K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.
High risk -
DrugsInternational Laboratories Corp. Ltd.
International Laboratories Corp. Ltd. failed manufacturing-practice rules for OTC drugs, including component identity testing and quality-unit oversight.
High risk -
DevicesIntegra LifeSciences Corporation
FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.
High risk -
DrugsAvaria Health & Beauty Corp.
FDA cites Avaria Health & Beauty for manufacturing-rule violations in OTC drugs, including missing glycerin identity testing and weak quality unit.
High risk -
DrugsSuhan Aerosol
Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.
High risk -
DrugsOrchid Lifesciences
FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.
High risk -
DrugsBaxter Healthcare Corporation
FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
DrugsLXR Biotech, LLC
FDA says LXR Biotech, a contract maker of an OTC drug, shipped batches without testing components or finished product.
High risk -
DrugsJamol Laboratories, Inc.
FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.
High risk -
FoodPorfirios Italian Foods, Inc.
FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.
High risk -
DrugsWise Women’s Choice
FDA warned Wise Women’s Choice that its natural birth control cream is an unapproved new drug sold with pregnancy-prevention claims.
High risk -
FoodBaits and Sea Foods, S.A.
FDA warns Baits and Sea Foods, S.A. over missing histamine, botulinum and allergen controls in mahi-mahi HACCP plan.
High risk -
BiologicsStratus Biosystems, LLC dba CellGenuity Regenerative Science
FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.
High risk